Qscreen AI Inc (PMEDF) Stock Analysis
Verdict: AVOID
A pre-revenue 'zombie' company with negative equity and a $311k cash pile that will likely expire within 4 months at current burn rates.
Investment score: 12/100
Analysis as of
Is Qscreen AI Inc stock worth reviewing? The TradeMates thesis
QScreen AI is a micro-cap exhibiting extreme financial distress. With a net loss of $1.16M against $311k in cash and zero revenue, existence is dependent on continuous dilution; the AI narrative lacks financial confirmation.
7-factor investment score
- Valuation: 5/100 (weight 20%)
- Financial Health: 5/100 (weight 15%)
- Technical Momentum: 25/100 (weight 15%)
- Earnings Quality: 10/100 (weight 15%)
- Insider Sentiment: 30/100 (weight 10%)
- Analyst Consensus: 20/100 (weight 10%)
- Risk-Adjusted Return: 10/100 (weight 15%)
Qscreen AI Inc opportunities and risks
What speaks for PMEDF
- Speculative AI Hype Cycle
What speaks against PMEDF
- Immediate Liquidity Exhaustion
Frequently asked questions about Qscreen AI Inc (PMEDF)
Is PMEDF stock a good investment?
The TradeMates model rates Qscreen AI Inc as AVOID with an investment score of 12/100. QScreen AI is a micro-cap exhibiting extreme financial distress. With a net loss of $1.16M against $311k in cash and zero revenue, existence is dependent on continuous dilution; the AI narrative lacks financial confirmation. This is algorithmic model output, not personal investment advice.
Is PMEDF stock a buy?
The TradeMates model verdict for PMEDF is AVOID with an investment score of 12/100. Treat this as a model signal to review, not a personal buy recommendation.